Curanex Pharmaceuticals Inc
CURX
$4.20
-$0.84-16.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.94M | 4.02M | 4.97M | 5.83M | 108.90K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.85M | 4.08M | 6.25M | 8.59M | 6.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 596.20K |
| Total Current Assets | 4.79M | 8.09M | 11.23M | 14.42M | 711.30K |
|
|
|||||
| Total Current Assets | 4.79M | 8.09M | 11.23M | 14.42M | 711.30K |
| Net Property, Plant & Equipment | 280.90K | 317.60K | 352.60K | 60.40K | 75.80K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 5.07M | 8.41M | 11.58M | 14.48M | 787.20K |
|
|
|||||
| Total Accounts Payable | 200.00 | 8.40K | 2.40K | 114.50K | 300.00 |
| Total Accrued Expenses | 9.70K | 13.20K | 11.90K | 10.30K | 5.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 94.40K | 107.10K | 122.70K | 61.20K | 70.60K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 104.30K | 128.70K | 137.00K | 186.00K | 75.90K |
|
|
|||||
| Total Current Liabilities | 104.30K | 128.70K | 137.00K | 186.00K | 75.90K |
| Long-Term Debt | -- | -- | -- | -- | 400.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 181.90K | 203.90K | 224.00K | -- | 5.80K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 286.30K | 332.60K | 361.00K | 186.00K | 481.70K |
|
|
|||||
| Common Stock & APIC | 16.08M | 16.08M | 16.07M | 16.07M | 925.70K |
| Retained Earnings | -11.29M | -8.00M | -4.85M | -1.77M | -820.40K |
| Treasury Stock & Other | -- | -- | -- | -- | 200.00K |
| Total Common Equity | 4.79M | 8.08M | 11.22M | 14.29M | 305.30K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
|
|
|||||
| Total Common Equity | 4.79M | 8.08M | 11.22M | 14.29M | 305.30K |
| Total Preferred Equity | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.79M | 8.08M | 11.22M | 14.29M | 305.40K |
|
|
|||||